For many of today’s new biomedical innovations, the distinctions between different forms of medical products such as drugs, diagnostics and devices no longer apply. Biomedicine also tends to realize its potential today through process innovation, even more than product innovation.
This workshop, held in Paris, sought to develop a vision and medium-term strategy for work on green research, technology and innovation.
English, , 351kb
This brochure describes the OECD Database on Research into the Safety of Manufactured Nanomaterials and how users can access, search and contribute to it.
This new edition of the OECD Economic Globalisation Indicators presents a broad range of indicators on trade, foreign direct investment, the economic activity of multinational firms, and the internationalisation of technology.
Innovation drives long-term economic growth. This book examines the role of innovation in developing countries, with a focus on Africa.
Cet ouvrage a pour objet de fournir des outils d’évaluation comparative de la durabilité de la production et de stimuler l’éco-innovation moyennant une meilleure compréhension des mécanismes de l’innovation.
This report is on how to support governments and industry in building a sustainable bio-based economy. The OECD Task Force on Industrial Biotechnology is considering the development of a set of recommendations in the area of Environmental and Economic Sustainability.
The main objectives of the panel were to launch the report from Montreal Workshop entitled “Towards the Development of OECD Best Practices for Assessing the Sustainability of Bio-based Products” and to communicate its main conclusions.
This document provides information on current/planned activities related to the safety of manufactured nanomaterials in OECD member and non-member countries that attended at the 7th meeting of OECD’s Working Party on Manufactured Nanomaterials (Paris France, 7-9 July 2010).
English, , 517kb
The purpose of the OECD Biotechnology Update is to provide up-to-date information on the diverse activities at OECD related to biotechnology.